I Altorjay
- Hepatology top 2%
- Liver Disease and Transplantation 11
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments 6
- Genetics top 5%
- Inflammatory Bowel Disease 24
- Epidemiology top 5%
- Microscopic Colitis 11
- Liver Disease Diagnosis and Treatment 8
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 6
-
- Eosinophilic Esophagitis 8
- Esophageal and GI Pathology 6
- Co-authors
- Mária PappPéter L. LakatosM. UdvardyKároly PalatkaIstván TornaiZsuzsanna VitálisWalter ReinischJ. Papp
- Cited by
- HepatologyGastroenterologyGenetics
- Journals
- Gastroenterology (5 papers)Inflammatory Bowel Diseases (5 papers)Journal of Hepatology (3 papers)
- Partner nations
- HungaryGermanyUnited States
In The Last Decade
I Altorjay
66 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 106
- Hepatology 352
- Gastroenterology 179
- Genetics 550
- Epidemiology 645
- Immunology 355
Countries citing papers authored by I Altorjay
This map shows the geographic impact of I Altorjay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Altorjay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Altorjay more than expected).
Fields of papers citing papers by I Altorjay
This network shows the impact of papers produced by I Altorjay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Altorjay. The network helps show where I Altorjay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside I Altorjay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2020 | 9 | |
| 3 | norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response | 2016 | 4 |
| 4 | 2013 | 116 | |
| 5 | 2010 | 69 | |
| 6 | 2010 | 12 | |
| 7 | 2010 | 2 | |
| 8 | 2009 | 160 | |
| 9 | 2009 | 27 | |
| 10 | 2008 | 71 | |
| 11 | 2008 | 18 | |
| 12 | 2008 | 14 | |
| 13 | 2008 | 51 | |
| 14 | 2007 | 4 | |
| 15 | 2007 | 32 | |
| 16 | 2006 | 20 | |
| 17 | 2005 | 48 | |
| 18 | 2005 | 2 | |
| 19 | 1989 | 1 | |
| 20 | [Esophageal perforation as a complication of handling of the newborn infant in the delivery room]. | 1979 | 1 |
About I Altorjay
I Altorjay is a scholar working on Gastroenterology, Hepatology, Genetics, Immunology and Epidemiology, having authored 69 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (24 papers), Liver Disease and Transplantation (11 papers), Microscopic Colitis (11 papers), Eosinophilic Esophagitis (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Gastroesophageal reflux and treatments (6 papers), Immunodeficiency and Autoimmune Disorders (6 papers) and Esophageal and GI Pathology (6 papers). The work is most often cited by research in Hepatology (352 citations), Gastroenterology (179 citations), Genetics (550 citations), Epidemiology (645 citations) and Immunology (355 citations). I Altorjay has collaborated with scholars based in Hungary, Germany and United States. Frequent co-authors include Mária Papp, Péter L. Lakatos, M. Udvardy, Károly Palatka, István Tornai, Zsuzsanna Vitális, Walter Reinisch, J. Papp, Jolán Hársfalvi and Gábor Veres. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, Journal of Hepatology, Journal of Crohn s and Colitis and Thrombosis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.